Insulet | PODD - Market Capitalization


Insulet reported $17.44B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Align Technology USD 12.04B 838M Feb/2026
AtriCure USD 1.61B 360M Feb/2026
Avanos Medical USD 700M 179M Feb/2026
Baxter International USD 9.54B 279M Feb/2026
Becton, Dickinson and Co. USD 51.01B 4.28B Feb/2026
Boston Scientific USD 110.32B 31.04B Feb/2026
Cardinal Health USD 54.98B 6.15B Feb/2026
Cooper Companies USD 13.9B 205M Sep/2025
Dexcom USD 25.44B 449M Feb/2026
Edwards Lifesciences USD 44.75B 4.72B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Globus Medical USD 12.61B 4.87B Feb/2026
ICU Medical USD 3.62B 93M Feb/2026
Inogen USD 121M 146M Sep/2023
Insulet USD 18.05B 1.95B Feb/2026
Integra LifeSciences USD 1.12B 163M Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Masimo USD 7.68B 1.44B Sep/2025
Medtronic USD 118.67B 10.66B Feb/2026
Merit Medical Systems USD 4.73B 201M Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Stryker USD 134.41B 6.92B Dec/2025
Tandem Diabetes Care USD 1.21B 278M Feb/2026
Teleflex USD 5.3B 73M Sep/2025
West Pharmaceutical Services USD 17.83B 1.96B Feb/2026
WK Kellogg Co USD 12.66B 464.02M Sep/2025
Zimmer Biomet Holdings USD 19.82B 2B Feb/2026